Results 261 to 270 of about 27,802 (306)

Viscoelastic Hemostatic Assays in the Management of Trauma-Induced Coagulopathy: A Clinical Update. [PDF]

J Clin Med
Natalini D, Xhemalaj R, Carelli S.
europepmc   +1 more source

DYNAMICS OF FIBRINOGEN AND FIBRIN DEGRADATION PRODUCTS DURING EXPERIMENTAL ACUTE LUNG INJURY

D.S. Ziablitsev
openalex   +2 more sources

Case Report: Managing coagulopathy in neonatal acute liver failure: insights from a case of rebalanced hemostasis and thromboelastography monitoring. [PDF]

Front Pediatr
Huang J, Ye M, Duan Q, Xiao W, Fu X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fibrinogen, fibrin degradation products and risk of sarcopenia

Clinical Nutrition, 2021
Increasing data suggests that chronic low-grade inflammation plays an important role on development of sarcopenia. The present study was designed to identify the association between fibrinogen, fibrin degradation products (FDP) and sarcopenia risk in hospitalized old patients.A total of 437 patients were enrolled in this cross-sectional study (148 with
Qian Xiao
exaly   +3 more sources

Determination of Urinary Fibrin/Fibrinogen Degradation Products by Radioimmunoassay

Scandinavian Journal of Clinical and Laboratory Investigation, 1976
Glomerular fibrin/fibrinogen related material is often found in the early stage of especially proliferative types of glomerulonephritis and during rejection of renal grafts after transplantation. The presence and concentration of urinary fibrin/fibrinogen degradation products (FDP) have been found to be correlated to the extent of glomerular fibrin ...
M, Ekberg, U, Hedner, I, Larsson, I M, Nilsson, B, Nosslin   +4 more
openaire   +2 more sources

Nature and Biological Activities of Degradation Products of Fibrinogen and Fibrin

Annual Review of Medicine, 1973
The recognition of the importance of fibrinogen proteolysis in a wide variety of pathological conditions ranging from disseminated intravascular coagulation to local fibrin deposition in renal diseases has led to numerous studies of the nature of the fibrinogen degradation products (FDP).
H C, Kwaan, G H, Barlow
openaire   +2 more sources

D-Dimer and Fibrinogen/Fibrin Degradation Products

2013
Although clinical requests for D-dimer are generally in the minority of assays in the routine clinical laboratory, they are an important aspect-especially if the laboratory supports an active emergency room and hematology service. Throughout the literature, D-dimer assays have been used for many purposes in the research setting; however it is generally
openaire   +2 more sources

A method for characterising serum fibrinogen and fibrin degradation products

Thrombosis Research, 1976
Abstract A method of characterising serum fibrinogen and fibrin degradation products is described. A commercial antiserum to human fibrinogen was covalently bound to agarose beads and used to precipitate fibrinogen related antigens from in vitro plasmin digests and from serum.
D A, Lane, M F, Scully, V V, Kakkar
openaire   +2 more sources

Effect of Fibrin Degradation Products and Thrombin on Fibrinogen Synthesis

British Journal of Haematology, 1979
Summary. The effect of intravenous administration of homologous fibrin degradation products and thrombin on fibrinogen synthesis was assessed in rabbits. The relative fibrinogen synthesis rate was calculated as a ratio of the amount of radiolabelled lysine incorporated into fibrinogen to the amount incorporated into albumin during the same measurement
T R, Ittyerah, N, Weidner, R D, Wochner, L A, Sherman   +3 more
openaire   +2 more sources